Pfizer Inc. entered into a definitive agreement to acquire two commercially marketed vaccines and related production facilities from Baxter International Inc. for approximately $640 million.
Jeffrey Symons, Dvir Oren, David Fox, Willard Boothby, Mattias Jonsson, David MacDonald, Scott Price and Steven Clemens of Kirkland & Ellis LLP acted as legal advisors and Credit Suisse Securities (USA) LLC acted as financial advisor for Pfizer. Horst Ebhardt, Hartwig Kienast, Katrin Stauber, Christoph Zechner, Kurt Retter, Wolfram Schachinger, Niklas Schmidt, Walter Poeschl, Roland Marko, Karl Binder, Libor Prokes, Anna Diblikova, Bill Finney and Pavel Srb of Wolf Theiss acted as legal advisors for Baxter. Christoph Mager, Elisabeth Stichmann, Daniel Varro, Johanna Höltl, Sabine Fehringer, Florian Schuhmacher and Christian Stuppnig of DLA Piper acted as legal advisors to Pfizer.
David J. Zampa, Thomas M. Thesing, Suresh T. Advani, Ken Glazer, Joshua T. Hofheimer, Laura L. Leonard, Mary C. Niehaus, Kristina Nordlander, Jeffrey S. Rothstein, Nicholas D. Turner, Luke J. Valentino, Vincenzo Salvatore, Alyse H. Andalman, Heather Barc, Nicola Bartholomew, Brendan M. Bowes, Rosanna Connolly, Angelene Duke, Patrick J. Harrison, Elizabeth L. Massaro, Yael M. Resnick and Matthew D. Stoker of Sidley Austin LLP acted as legal advisors to Baxter International. The Goldman Sachs Group, Inc. (NYSE:GS) acted as a financial advisor and PricewaterhouseCoopers LLP ed as an accountant (tax) to Baxter International. Deloitte Touche Tohmatsu acted as an accountant (tax) to Pfizer Inc. The currency conversion was done through www.oanad.com on August 11, 2014.